drugset

drugset / Trial / NCT05881213

Clinical Trial to Investigate the Pharmacokinetics and Safety After Oral Administration of CKD-378 and Co-administration of D745, D150, D029 in Healthy Adults

NCT05881213 ↗

Phase 1 Completed 23 enrolled Chong Kun Dang Pharmaceutical

RandomizedCrossoverOpen-labelTreatment

Summary

A clinical trial to compare and evaluate the safety and pharmacokinetics of CKD-378

Timeline

Start: 2023-06-01
Primary completion: 2023-06-28
Completion: 2023-07-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	CKD-378	Unknown	—	Oral

Indications